$136.13
0.26%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.
ISIN
US45784P1012
Symbol
PODD

Insulet Corporation Target price 2026 - Analyst rating & recommendation

Insulet Corporation Classifications & Recommendation

Buy
61%
Hold
39%

Insulet Corporation Price Target

Target Price $175.95
Price $136.13
Potential
Number of Estimates 26
26 Analysts have issued a price target Insulet Corporation 2027 . The average Insulet Corporation target price is $175.95. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 33 analysts: 20 Analysts recommend Insulet Corporation to buy, 13 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Insulet Corporation stock has an average upside potential 2027 of . Most analysts recommend the Insulet Corporation stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 2.71 3.36
30.73% 23.89%
EBITDA Margin 20.83% 23.97%
10.75% 15.05%

30 Analysts have issued a sales forecast Insulet Corporation 2026 . The average Insulet Corporation sales estimate is

$3.4b
unlock
. This is
9.87% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.5b 14.52%
unlock
, the lowest is
$3.1b 2.41%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.7b 30.73%
2026
$3.4b 23.89%
unlock
2027
$3.8b 13.98%
unlock
2028
$4.4b 14.36%
unlock
2029
$5.5b 24.99%
unlock
2030
$6.0b 8.85%
unlock
2031
$6.9b 16.39%
unlock
2032
$7.8b 12.40%
unlock
2033
$7.4b 4.47%
unlock

26 Analysts have issued an Insulet Corporation EBITDA forecast 2026. The average Insulet Corporation EBITDA estimate is

$804m
unlock
. This is
30.74% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$867m 40.88%
unlock
, the lowest is
$699m 13.59%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $564m 44.78%
2026
$804m 42.54%
unlock
2027
$946m 17.61%
unlock
2028
$1.1b 19.36%
unlock
2029
$1.5b 30.74%
unlock
2030
$1.7b 17.07%
unlock

EBITDA Margin

2025 20.83% 10.75%
2026
23.97% 15.05%
unlock
2027
24.73% 3.17%
unlock
2028
25.82% 4.41%
unlock
2029
27.00% 4.57%
unlock
2030
29.04% 7.56%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 3.43 6.59
39.40% 92.13%
P/E 20.66
EV/Sales 2.88

29 Analysts have issued a Insulet Corporation forecast for earnings per share. The average Insulet Corporation EPS is

$6.59
unlock
. This is
22.04% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$6.90 27.78%
unlock
, the lowest is
$5.29 2.04%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $3.43 39.40%
2026
$6.59 92.13%
unlock
2027
$7.77 17.91%
unlock
2028
$9.34 20.21%
unlock
2029
$12.84 37.47%
unlock
2030
$14.77 15.03%
unlock
2031
$16.60 12.39%
unlock
2032
$19.01 14.52%
unlock
2033
$17.53 7.79%
unlock

P/E ratio

Current 25.21 74.55%
2026
20.66 18.05%
unlock
2027
17.53 15.15%
unlock
2028
14.58 16.83%
unlock
2029
10.60 27.30%
unlock
2030
9.21 13.11%
unlock
2031
8.20 10.97%
unlock
2032
7.16 12.68%
unlock

Based on analysts' sales estimates for 2026, the Insulet Corporation stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.17 68.43%
2026
2.88 9.04%
unlock
2027
2.53 12.26%
unlock
2028
2.21 12.55%
unlock
2029
1.77 20.00%
unlock
2030
1.63 8.14%
unlock
2031
1.40 14.08%
unlock
2032
1.24 11.04%
unlock

P/S ratio

Current 3.09 68.67%
2026
2.81 8.98%
unlock
2027
2.47 12.27%
unlock
2028
2.16 12.55%
unlock
2029
1.73 20.00%
unlock
2030
1.59 8.13%
unlock
2031
1.36 14.08%
unlock
2032
1.21 11.03%
unlock

Current Insulet Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Leerink Partners
Locked
➜
Locked
Locked Aug 06 2026
Benchmark
Locked
➜
Locked
Locked Aug 06 2026
BTIG
Locked
➜
Locked
Locked Aug 06 2026
JP Morgan
Locked
➜
Locked
Locked Aug 06 2026
Bernstein
Locked
➜
Locked
Locked Aug 06 2026
Canaccord Genuity
Locked
➜
Locked
Locked Aug 06 2026
RBC Capital
Locked
➜
Locked
Locked Aug 06 2026
Analyst Rating Date
Locked
Leerink Partners:
Locked
➜
Locked
Aug 06 2026
Locked
Benchmark:
Locked
➜
Locked
Aug 06 2026
Locked
BTIG:
Locked
➜
Locked
Aug 06 2026
Locked
JP Morgan:
Locked
➜
Locked
Aug 06 2026
Locked
Bernstein:
Locked
➜
Locked
Aug 06 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Aug 06 2026
Locked
RBC Capital:
Locked
➜
Locked
Aug 06 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today